Nalaganje...

No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients

The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transiliac bone biopsy samples (n = 66) from postmenopausal...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Bone Rep
Main Authors: Misof, Barbara M., Roschger, Paul, Zhou, Hua, Nieves, Jeri W., Bostrom, Mathias, Cosman, Felicia, Lindsay, Robert, Klaushofer, Klaus, Dempster, David W.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7090359/
https://ncbi.nlm.nih.gov/pubmed/32215284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100253
Oznake: Označite
Brez oznak, prvi označite!